Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 220 participants.
Also called NCT02679261
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 220 participants
- Registry
-
NCT02679261
-
- Other papers using this trial's data
- Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT02679261. Randomized; quadruple masking; primary purpose treatment. Start 2016-06 (actual); primary completion 2021-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve
- Acronym
- BICATOR
- Condition
- Bicuspid Aortic Valve
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
Record details
- Record id
cardio:ct-nct02679261- Content hash
77ede48e2c9058792f9582c2606c6236a74962e4fbd901f119779bd7aeb095e1